Aspen Neuroscience News and Activities

Acquisition, funding and merger involving Aspen Neuroscience.

• Aspen Neuroscience has just announced a $115 Million fundraising (posted on November 21 2025).

View the org chart displaying its 33 main executives

Most searched biographies at Aspen Neuroscience

• Damien McDevitt, Director, President and Chief Executive Officer
• Tom Daniel, Director
• Doug Fisher, Director

Popular executive movements at Aspen Neuroscience

• Revati Shreeniwas has joined the company as Chief Medical Officer  (posted on January 7 2026).
• Lisa Johnson-Pratt, who was Senior Vice President, Therapeutic Program, is promoted to Chief Commercial Officer  (posted on January 7 2026).

Create your alert
to follow the executive moves at Aspen Neuroscience.

Aspen Neuroscience has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Aspen Neuroscience

• Endpoints News Honors Aspen Neuroscience Co-Founder Dr. Jeanne Loring in "20 Women Breaking New Ground"
• Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer
• First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station | Business Wire
• PR Newswire: press release distribution, targeting, monitoring and marketing
• Aspen Neuroscience Announces Management Transition
• Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
• Aspen Neuroscience Announces Board of Directors and Scientific Advisory Board
• Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
• Press Releases — Aspen Neuroscience
• View more press releases Close

Social media about Aspen Neuroscience

• Aspen Neuroscience on Wikipedia, Google News & Yahoo Finance
• Aspen Neuroscience on LinkedIn, X (Twitter) & YouTube